Pricing

Genfit SA (GNFT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Pascal Prigent
Employees:
120
PARC EURASANTE, 885, AVENUE EUGENE AVINEE, LOOS, I0, 59120
33 3 20 16 4000
Genfit S.A. discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Elafibranor is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available